These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31649816)

  • 21. [Healthcare-associated infections and antimicrobial use in long term care facilities (HALT-2): German results of the second European prevalence survey].
    Ruscher C; Kraus-Haas M; Nassauer A; Mielke M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Apr; 58(4-5):436-51. PubMed ID: 25739563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A; Fasuyi T; Aigbovo O; Versporten A; Adekanmbi O; Akinyemi O; Goossens H; Kehinde A; Oduyebo O
    West Afr J Med; 2020; 37(3):216-220. PubMed ID: 32476113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
    Loftus MJ; Curtis SJ; Naidu R; Cheng AC; Jenney AWJ; Mitchell BG; Russo PL; Rafai E; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):146. PubMed ID: 32859255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial consumption and bacterial resistance pattern in patients admitted in I.C.U at a tertiary care center.
    Saxena S; Priyadarshi M; Saxena A; Singh R
    J Infect Public Health; 2019; 12(5):695-699. PubMed ID: 31000490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point Prevalence Survey of Antimicrobial Prescription and Consumption in a Nigerian Tertiary Hospital: A Gateway to the Antimicrobial Stewardship Program.
    Nwafia IN; Nwachukwu PT; Orakwe O; Ebede SO; Amagwu C; Aroh A; Orabueze O; Ndubueze C; Okeke P; Ijere O; Izundu D; Ohanu M; Ozumba U; Oduyebo O; Versporten A
    Niger J Clin Pract; 2024 Jun; 27(6):702-707. PubMed ID: 38943293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surveillance of antibiotic agents according to § 23 of the German Infection Protection Act-data and results from hospitals in Frankfurt am Main, Germany, 2012-2017].
    Heudorf U; Hausemann A; Steul K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Sep; 62(9):1092-1102. PubMed ID: 31432202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P; Goossens H
    Drugs; 2011 Apr; 71(6):745-55. PubMed ID: 21504250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent antibiotic use in German acute care hospitals - from benchmarking to improved prescribing and quality care].
    Kern WV; Fellhauer M; Hug M; Hoppe-Tichy T; Först G; Steib-Bauert M; de With K
    Dtsch Med Wochenschr; 2015 Nov; 140(23):e237-46. PubMed ID: 26583825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of linezolid prescriptions in three French hospitals.
    Dentan C; Forestier E; Roustit M; Boisset S; Chanoine S; Epaulard O; Pavese P
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1133-1141. PubMed ID: 28127641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011.
    Reilly JS; Price L; Godwin J; Cairns S; Hopkins S; Cookson B; Malcolm W; Hughes G; Lyytikainen O; Coignard B; Hansen S; Suetens C;
    Euro Surveill; 2015 Feb; 20(8):. PubMed ID: 25742434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009.
    Zarb P; Amadeo B; Muller A; Drapier N; Vankerckhoven V; Davey P; Goossens H;
    J Antimicrob Chemother; 2011 Feb; 66(2):443-9. PubMed ID: 21084362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance of antimicrobial utilization in Africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys.
    Gobezie MY; Tesfaye NA; Faris AG; Hassen M
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):101. PubMed ID: 39256804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveys.
    Hopmans TEM; Smid EA; Wille JC; van der Kooi TII; Koek MBG; Vos MC; Geerlings SE; de Greeff SC
    J Hosp Infect; 2020 Feb; 104(2):181-187. PubMed ID: 31626863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Ricchizzi E; Latour K; Kärki T; Buttazzi R; Jans B; Moro ML; Nakitanda OA; Plachouras D; Monnet DL; Suetens C; Kinross P;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redundant Anaerobic Antimicrobial Prescriptions in German Acute Care Hospitals: Data from a National Point Prevalence Survey.
    Aghdassi SJS; Gastmeier P; Behnke M; Hansen S; Kramer TS
    Antibiotics (Basel); 2020 May; 9(6):. PubMed ID: 32481490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis.
    Rodríguez-Baño J; Pérez-Moreno MA; Peñalva G; Garnacho-Montero J; Pinto C; Salcedo I; Fernández-Urrusuno R; Neth O; Gil-Navarro MV; Pérez-Milena A; Sierra R; Estella Á; Lupión C; Irastorza A; Márquez JL; Pascual Á; Rojo-Martín MD; Pérez-Lozano MJ; Valencia-Martín R; Cisneros JM;
    Clin Microbiol Infect; 2020 Mar; 26(3):358-365. PubMed ID: 31323260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.